BusinessScience 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections that can Advance Scientific Innovation and EntrepreneurshipBy Nasdaq OMXMay 4, 2018, 2:00 PM UTC
BusinessEmerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy StoresBy Nasdaq OMXApr 17, 2018, 11:01 AM UTC
BusinessAtlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research InstitutionsBy Nasdaq OMXApr 12, 2018, 1:01 PM UTC
BusinessJohn Poss, Chief Executive Officer of GB Sciences, Inc., Returns to Uptick Newswire’s “Stock Day” Podcast with Everett Jolly for Operational UpdateBy Nasdaq OMXFeb 6, 2018, 2:00 PM UTC
BusinessTeneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific AntibodiesBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
BusinessFive Prime Therapeutics to Present at 36th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 3, 2018, 9:06 PM UTC
BusinessSchrödinger and MaRS Innovation Announce the Launch of Bright Angel TherapeuticsBy Nasdaq OMXDec 21, 2017, 1:00 PM UTC
BusinessFibrocor Therapeutics Appoints Its First President & CEOBy Nasdaq OMXNov 28, 2017, 1:00 PM UTC
